SHREVEPORT, La. - It's estimated that up to 70% of people over the age of 70 may suffer from some form of sleep apnea, the ...

Long-term use of melatonin supplements for sleep may be linked to a greater risk for heart failure, a recent study suggests.

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

VA vowed to modernize its disability benefits system. As criticism from veterans and their advocates has mounted, efforts to ...

The Food and Drug Administration has approved a GLP-1 agonist for treating sleep apnea. Here’s how it works and what you can ...

Undiagnosed sleep apnea in women has reached a tipping point, with emerging sex-specific sleep research poised to reshape how ...

Obstructive Sleep Apnea (OSA) is a common yet underdiagnosed sleep disorder characterized by repetitive upper airway collapse during sleep, leading to ...

A sleep apnea device company that’s been a darling of Minnesota’s medtech scene lost more than 40% of its value in the past five days as investors realized the competitive threat posed by new weight ...

Looking for a truly restful and regenerative holiday during the winter months? Consider these sleep-friendly destinations across Europe, renowned for things like air quality and low light pollution.

TUESDAY, Oct. 21, 2025 (HealthDay News) — Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients ...

Just as a single night of insomnia may leave you feeling groggy and cranky, solid slumber can help you feel rested and ready to take on the day. How well you sleep over time, however, can influence ...

Plaintiffs are going to court to challenge CVS Caremark’s decision to stop covering Zepbound, a weight-loss drug that is also used to treat sleep apnea. Plaintiff Martin Hamburger filed his lawsuit in ...